United States · Platforms & data · Investing.com

Alpha Cognition reports Q3 revenue growth for Alzheimer’s drug

Published by Investing.com · United States 1 h ago

Alpha Cognition reports Q3 revenue growth for Alzheimer’s drug — Investing.com

Read the full article on Investing.com Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.investing.com)

Also worth reading

Bloom Energy’s stock is rallying as data-center jitters subside

CareTrust REIT (NYSE:CTRE) Price Target Raised to $46.00

Prediction markets tied to clinical trials and drug approvals draw lawmakers' ire

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030

Sunbelt Rentals to Announce Second Quarter Fiscal Year 2027 Results on December 8, 2026

Republicans Prepared To Subpoena Nvidia CEO Over Alleged Chinese Spy Links: Report